Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly D-cycloserine for Cognitive Function in Schizophrenia
NCT00455702Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2004
- Primary completion
- Apr 2007
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of d-cycloserine in schizophrenia, sponsored by Massachusetts General Hospital. Started Jul 2004; status: completed.
02
Drugs
d-cycloserine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00455702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455702.